# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
1 | 04-16-2024 | 12-31-2023 | 10-K | |
2 | 11-20-2023 | 09-30-2023 | 10-Q | |
3 | 09-22-2023 | 06-30-2023 | 10-Q |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Companies Reporting Before The Bell • Tilray Brands (NASDAQ:TLRY) is projected to report quarterly loss at $0.05 per share on ...
NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE:NRXS), a medical technology company commercializing neuromo...
NeurAxis, Inc. (NYSE American: NRXS) ("NeurAxis" or the "Company"), a medical technology company commercializin...
Neuraxis (AMEX:NRXS) reported quarterly losses of $(1.35) per share. This is a 18.42 percent decrease over losses of $(1.14) pe...
NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE:NRXS), a medical technology company commercializing neuromo...
NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE:NRXS), a medical technology company commercializing neuromo...